Explore the Agenda
Workshop A 워크숍 A
9:30 am Crossing Important Development Milestones to De-Risk Your TPD Candidates & Enable Global Industry-Standard Compliant Drug Profiles For Your Degraders
As Korean biotechs advance from discovery toward clinical development, the transition often exposes critical gaps in technical standards and strategic planning. This workshop will provide actionable guidance on implementing global best practices for assay design, selectivity profiling, and translational alignment, while addressing the unique challenges faced by emerging TPD companies in Asia. Attendees will gain clarity on what global partners expect, how to structure industry standard compliant data packages, and how to better transition into the clinic.
Key Takeaways:
- Defining assay standards for TPD modalities to ensure mechanistic clarity, meet global expectations and strengthen confidence in clinical readiness
- Integrating hypothesis-driven development roadmaps to align discovery with translational milestones, reduce costly pitfalls and accelerate clinical data package preparation
- The discovery of clinical-stage BTK degrader, BGB-16673and overcoming on-target resistance from BTK inhibitors
12:30 pm Lunch
Workshop B 워크숍 B
1:30 pm Integrating Novel Platforms & AI Technologies Into Your Workflows to Improve Target Validation, Accelerate Discovery & Enable Scalable PROTAC & Molecular Glue Development
This workshop will help attendees master two critical enabling technologies, proteomics and AI. Discussions will revolve around how to design and apply proteomics workflows for selectivity profiling and mechanistic clarity, and how to use AI-driven analytics to interpret complex datasets and accelerate degrader design and modeling. By the end of the session, attendees will have practical strategies to improve reliable data generation and analysis and how to use this to inform critical drug design decisions.
Key Takeaways:
- Integrating high-throughput discovery platforms into your workflows to accelerate the discovery and development of molecular glues
- Beyond screening: Accelerating TPD and induced proximity discovery with agentic AI and large language models
- Exploring case studies on how advanced biotechs combine the latest platform technology and AI tools to reduce experimental burden, improve translational predictability, and enable scalable discovery
4:00 pm Networking Session
Final chance to network with fellow attendees ahead of the main conference days.